Mannkind Corp (MNKD)

May 01, 2025

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025 - The Globe and Mail

May 01, 2025

Apr 29, 2025

The Potential Rise in the Price of Mannkind Corp (MNKD) following insiders activity - knoxdaily.com

Apr 29, 2025

Apr 29, 2025

Solidion Technology Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025

Apr 23, 2025

MNKD (Mannkind Corp) may reap gains as insiders became active recently - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

Mannkind Corp (MNKD) is looking forward to a strong quarter - Sete News

Apr 23, 2025

Apr 18, 2025

Is MannKind Corporation (MNKD) the Best Quality Penny Stock to Buy According to Hedge Funds? (READY TO EDIT2) - Insider Monkey

Apr 18, 2025

Apr 16, 2025

Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 16, 2025

Apr 16, 2025

MannKind Becomes Oversold (MNKD) - Nasdaq

Apr 16, 2025

Apr 15, 2025

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Apr 15, 2025

Apr 12, 2025

MannKind (NASDAQ:MNKD) Upgraded at Mizuho - Defense World

Apr 12, 2025

Apr 10, 2025

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Apr 10, 2025

Apr 09, 2025

Mizuho sets MannKind stock Outperform with $12 target - Investing.com

Apr 09, 2025

Apr 09, 2025

Mizuho sets MannKind stock Outperform with $12 target By Investing.com - Investing.com India

Apr 09, 2025

Apr 07, 2025

Diabetes Meets Racing: MannKind's Game-Changing Partnership With Type 1 Diabetic IndyCar Star - Stock Titan

Apr 07, 2025

Apr 07, 2025

MannKind To Support Conor Daly - Speed Sport

Apr 07, 2025

Mar 28, 2025

FTNT Stock Sees Surge of Approximately 1.11% in Last Five Days - knoxdaily.com

Mar 28, 2025

Mar 21, 2025

Cantor maintains Overweight rating on MannKind stock at $9 target - Investing.com

Mar 21, 2025

Mar 19, 2025

Why It's Worth Keeping An Eye On MannKind - RTTNews

Mar 19, 2025

Mar 18, 2025

Inhalable Biologics Industry Report 2025: World Market to Nearly Triple in Size by 2030, Reaching $10.06 Billion at a CAGR of 17.6% - Yahoo Finance

Mar 18, 2025

Mar 12, 2025

MannKind at Barclays Healthcare Conference: Strategic Growth and Innovation - Investing.com India

Mar 12, 2025

Mar 11, 2025

MAC Lung Disease Market Statistics Expected to Experience Major - openPR

Mar 11, 2025

Mar 10, 2025

MannKind Corporation Showcases Positive Outcomes of Inhaled Insulin at ATTD 2025 with Anticipated sNDA Filing for Pediatric Use in 2025 - Nasdaq

Mar 10, 2025

Mar 10, 2025

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22 - Yahoo Finance

Mar 10, 2025

Mar 07, 2025

AllPennyStocks.com News: Companies Looking Towards Future Revenue with New Diabetes Therapies - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

Commit To Purchase MannKind At $3, Earn 13.3% Using Options - Nasdaq

Mar 07, 2025

Mar 04, 2025

Non- Tuberculous Mycobacterial Infections Market on Track for Major Expansion by 2034, According to DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharma - Barchart

Mar 04, 2025

Mar 04, 2025

Non- Tuberculous Mycobacterial Infections Market on Track - openPR

Mar 04, 2025

Mar 02, 2025

MannKind’s (MNKD) Outperform Rating Reiterated at Wedbush - Defense World

Mar 02, 2025

Mar 02, 2025

MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’ - MSN

Mar 02, 2025

Mar 01, 2025

MannKind Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance

Mar 01, 2025

Feb 28, 2025

MannKind Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus.com

Feb 28, 2025

Feb 27, 2025

MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In Question - Seeking Alpha

Feb 27, 2025

Feb 27, 2025

MannKind Corporation (NASDAQ:MNKD) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025

Feb 27, 2025

MannKind: Q4 Earnings Snapshot - mySA

Feb 27, 2025

Feb 27, 2025

MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Re - GuruFocus.com

Feb 27, 2025

Feb 27, 2025

MannKind Corp Q4 Earnings: EPS Meets Estimates at $0.03, Revenue Surpasses Expectations at $77 Million - GuruFocus.com

Feb 27, 2025

Feb 27, 2025

MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Feb 27, 2025

Feb 26, 2025

Mannkind stock gains amid Q4 report, business update - MSN

Feb 26, 2025

Feb 26, 2025

MannKind Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2025

Feb 26, 2025

MannKind (MNKD) Q4 Earnings Meet Estimates - Yahoo Finance

Feb 26, 2025

Feb 26, 2025

Earnings call transcript: MannKind Q4 2024 beats EPS forecast, stock jumps - Investing.com

Feb 26, 2025

Feb 26, 2025

MannKind earnings beat by $0.05, revenue topped estimates - Investing.com

Feb 26, 2025

Feb 26, 2025

MannKind shares move 4% higher on strong revenue growth By Investing.com - Investing.com South Africa

Feb 26, 2025